A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Deciphera Pharmaceuticals, LLC
University of Liege
Massachusetts General Hospital
Amgen
Pierre Fabre Medicament
Merck Sharp & Dohme LLC
National Institute of Allergy and Infectious Diseases (NIAID)
AbbVie
National Institutes of Health Clinical Center (CC)
Kaiser Permanente